News in Brief

MilliporeSigma opens $115m life science centre in Massachusetts

By Staff Reporter

- Last updated on GMT


Related tags: Life

MilliporeSigma has cut the ribbon on a life science site in Burlington that incorporates a biomanufacturing equipment education centre.

Ground was broken on the 280,000 sq ft facility in Burlington, Massachusetts in July 2016​, and 15 months later MilliporeSigma – the life science division of Germany’s Merck – has opened the doors on its $115m (€97m) investment.

The site will serve as a hub for drugmakers looking to find solutions for their bioprocessing needs, MilliporeSigma said, and includes an “M Lab Collaboration Center” ​offering a full-scale non-GMP pilot lab and process development lab expected to serve more than 500 customers per year.

CEO Udit Batra said the campus “is specifically designed to foster a hands-on, collaborative environment where customers and our scientists and engineers come together to solve the toughest problems in life science.”

Burlington replaces the company’s nearby Billerica lab, with 850 full-time employees currently at the relocating to the new campus.

The M Lab concept is being launched globally with MilliporeSigma offering the same services across eight sites from France to South Korea.

Related news

Show more

Related products

show more

Cultivation of 3D Cell Aggregates in Perfusion

Cultivation of 3D Cell Aggregates in Perfusion

Eppendorf for Bioprocess – Solutions that grow with you | 21-May-2018 | Application Note

3D cell aggregates are of great interest for applications like disease modeling and manufacturing of stem cell-based products. Read more about the cultivation...

Next generation single-use connector

Next generation single-use connector

Pall Life Sciences | 02-May-2018 | Technical / White Paper

Assuring sterility, traceability, and quality for your single-use fluid handling.

The Kleenpak® Presto sterile connector is the only connector...

High-Density Vero Cell Perfusion Culture

High-Density Vero Cell Perfusion Culture

Eppendorf for Bioprocess – Solutions that grow with you | 01-May-2018 | Application Note

Viral diseases like rabies, rotavirus and influenza are causing many deaths worldwide, resulting in a strong demand for more productive manufacturing techniques...

Nifty Biosimilar

Nifty Biosimilar

UGA Biopharma | 13-Mar-2018 | Research Study

Aflibercept (Zaltrap®) is a recombinant fusion protein with complex post-translational modifications. Therefore deep understanding of biosimilar development...

Related suppliers